Białecki R - Search Results

1

Methodology of generation of CFD meshes and 4D shape reconstruction of coronary arteries from patient-specific dynamic CT.

Psiuk-Maksymowicz K, Borys D, Melka B, Gracka M, Adamczyk WP, Rojczyk M, Wasilewski J, Głowacki J, Kruk M, Nowak M, Ostrowski Z, Bialecki RA. Psiuk-Maksymowicz K, et al. Among authors: bialecki ra. Sci Rep. 2024 Jan 25;14(1):2201. doi: 10.1038/s41598-024-52398-5. Sci Rep. 2024. PMID: 38273032 Free PMC article.

2

SC2EGSet: StarCraft II Esport Replay and Game-state Dataset.

Białecki A, Jakubowska N, Dobrowolski P, Białecki P, Krupiński L, Szczap A, Białecki R, Gajewski J. Białecki A, et al. Among authors: bialecki r. Sci Data. 2023 Sep 8;10(1):600. doi: 10.1038/s41597-023-02510-7. Sci Data. 2023. PMID: 37684293 Free PMC article.

3

The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR.

Steffen J, Ngo J, Wang SP, Williams K, Kramer HF, Ho G, Rodriguez C, Yekkala K, Amuzie C, Bialecki R, Norquay L, Nawrocki AR, Erion M, Pocai A, Shirihai OS, Liesa M. Steffen J, et al. Among authors: bialecki r. Mol Metab. 2022 Oct;64:101566. doi: 10.1016/j.molmet.2022.101566. Epub 2022 Aug 6. Mol Metab. 2022. PMID: 35940556 Free PMC article.

4

Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys.

Chen Y, Dale Thurman J, Kinter LB, Bialecki R, Eric McDuffie J. Chen Y, et al. Among authors: bialecki r. Toxicol Appl Pharmacol. 2017 Dec 1;336:66-74. doi: 10.1016/j.taap.2017.10.010. Epub 2017 Oct 16. Toxicol Appl Pharmacol. 2017. PMID: 29051111

5

Quantitative pharmacokinetic-pharmacodynamic modelling of baclofen-mediated cardiovascular effects using BP and heart rate in rats.

Kamendi H, Barthlow H, Lengel D, Beaudoin ME, Snow D, Mettetal JT, Bialecki RA. Kamendi H, et al. Among authors: bialecki ra. Br J Pharmacol. 2016 Oct;173(19):2845-58. doi: 10.1111/bph.13561. Epub 2016 Aug 25. Br J Pharmacol. 2016. PMID: 27448216 Free PMC article.

6

Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology.

Kamendi H, Zhou Y, Crosby M, Keirstead N, Snow D, Bentley P, Patel N, Barthlow H, Luo W, Dragan Y, Bialecki R. Kamendi H, et al. Among authors: bialecki r. Toxicol Appl Pharmacol. 2015 Dec 15;289(3):560-72. doi: 10.1016/j.taap.2015.10.002. Epub 2015 Oct 9. Toxicol Appl Pharmacol. 2015. PMID: 26450648

7

CNS Adverse Effects: From Functional Observation Battery/Irwin Tests to Electrophysiology.

Fonck C, Easter A, Pietras MR, Bialecki RA. Fonck C, et al. Among authors: bialecki ra. Handb Exp Pharmacol. 2015;229:83-113. doi: 10.1007/978-3-662-46943-9_4. Handb Exp Pharmacol. 2015. PMID: 26091637 Review.

8

Repeated exposure to low doses of kainic acid activates nuclear factor kappa B (NF-κB) prior to seizure in transgenic NF-κB/EGFP reporter mice.

Miller JA, Kirkley KA, Padmanabhan R, Liang LP, Raol YH, Patel M, Bialecki RA, Tjalkens RB. Miller JA, et al. Among authors: bialecki ra. Neurotoxicology. 2014 Sep;44:39-47. doi: 10.1016/j.neuro.2014.04.010. Epub 2014 May 9. Neurotoxicology. 2014. PMID: 24813937 Free PMC article.

9

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions.

Ewart L, Milne A, Adkins D, Benjamin A, Bialecki R, Chen Y, Ericsson AC, Gardner S, Grant C, Lengel D, Lindgren S, Lowing S, Marks L, Moors J, Oldman K, Pietras M, Prior H, Punton J, Redfern WS, Salmond R, Skinner M, Some M, Stanton A, Swedberg M, Finch J, Valentin JP. Ewart L, et al. Among authors: bialecki r. J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):30-43. doi: 10.1016/j.vascn.2013.04.008. Epub 2013 May 9. J Pharmacol Toxicol Methods. 2013. PMID: 23665080

10

Assessment of cisplatin-induced kidney injury using an integrated rodent platform.

Chen Y, Brott D, Luo W, Gangl E, Kamendi H, Barthlow H, Lengel D, Fikes J, Kinter L, Valentin JP, Bialecki R. Chen Y, et al. Among authors: bialecki r. Toxicol Appl Pharmacol. 2013 May 1;268(3):352-61. doi: 10.1016/j.taap.2013.01.032. Epub 2013 Feb 13. Toxicol Appl Pharmacol. 2013. PMID: 23415679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page